Previous 10 | Next 10 |
Suwanee, GA, April 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB:SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today comme...
Suwanee, GA, April 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) ( www.sanuwave.com ) announced they have entered North and South Carolina as their 5th and 6th markets in 2019, also hiring David Cummings to lead SANUWAVE in the Carolinas...
SUWANEE, GA / ACCESSWIRE / April 22, 2019 / SANUWAVE Health, Inc. (OTCQB: SNWV) ( www.sanuwave.com ) SANUWAVE Health, Inc. is an emerging regenerative medicine company focused on the development and commercialization of noninvasive, biological response activating devices for the repair and r...
SUWANEE, GA, April 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCBB: SNWV) is pleased to provide an update regarding the Company’s regulatory status in the worldwide sales and distribution of the company’s medical devices. In addition ...
Suwanee, GA, April 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCBB: SNWV) ( www.sanuwave.com ): SANUWAVE® is pleased to announce initial enrollment beginning this week in two company-sponsored studies. First, SANUWAVE is sponsoring an initial case ...
SUWANEE, GA, April 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, received United S...
SANUWAVE Health, Inc (SNWV) Q4 2018 Results Earnings Conference Call March 29, 2019, 10:00 AM ET Company Participants Lisa Sundstrom - CFO Kevin Richardson - Chairman and Chief Executive Officer Pete Stegagno - COO Iulian Cioanta - Chief Science Officer Shri Parikh - Preside...
SANUWAVE Health ( OTCQB:SNWV ): FY GAAP EPS of -$0.08 beats by $0.01 . More news on: SANUWAVE Health, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
SUWANEE, Ga., March 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) will report financial results for the year ended December 31, 2018 with the SEC on Monday, April 1, 2019. The Company will also host a conference call today, March 29, 2019 at 10...
SUWANEE, GA, March 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will host a conference call on Friday, March 29, 2019, beginning at 10AM Eastern Time to discuss the 2018 financial results, provide a business upd...
News, Short Squeeze, Breakout and More Instantly...
Sanuwave Health Inc Company Name:
SNWV Stock Symbol:
OTCMKTS Market:
Q1 2024 revenues were $5.8 million, up 53% from Q1 2023 Q1 2024 gross margin was 73%, up 600bp from Q1 2023 Operating loss was $1.1 million for Q1 2024 compared to $2.0 million for Q1 2023 Company provides guidance for revenue growth of 45-55% for Q2 2024 versus Q2 2023 and reit...
EDEN PRAIRIE, MN - ( NewMediaWire ) - May 07, 2024 - SANUWAVE Health, Inc. (the "Company" or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, May 10, 2024, at 8:30 AM (ET) to present the Q1 2024 f...
SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31, 2024. This represents the highest Q1 revenues in company history. Q1 2024 revenue increased between 51% and 56% compared to Q1 2023. UltraMist revenues for Q1 2...